NM_001350709.2(DGKB):c.512G>A (p.Ser171Asn) AND not specified

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Apr 8, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004199391.1

Allele description [Variation Report for NM_001350709.2(DGKB):c.512G>A (p.Ser171Asn)]

NM_001350709.2(DGKB):c.512G>A (p.Ser171Asn)

Gene:

DGKB:diacylglycerol kinase beta [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7p21.2

Genomic location:

Preferred name:

NM_001350709.2(DGKB):c.512G>A (p.Ser171Asn)

Other names:

NM_004080.2:c.512G>A

HGVS:

NC_000007.14:g.14701685C>T
NG_029494.2:g.278093G>A
NM_001350705.1:c.512G>A
NM_001350706.2:c.512G>A
NM_001350707.2:c.512G>A
NM_001350708.1:c.512G>A
NM_001350709.2:c.512G>AMANE SELECT
NM_001350711.2:c.491G>A
NM_001350712.1:c.491G>A
NM_001350714.2:c.491G>A
NM_001350715.1:c.491G>A
NM_001350716.2:c.491G>A
NM_001350717.2:c.512G>A
NM_001350718.1:c.512G>A
NM_001350719.2:c.512G>A
NM_001350720.1:c.491G>A
NM_001350721.2:c.491G>A
NM_001350722.2:c.386G>A
NM_001350723.2:c.386G>A
NM_001350724.2:c.365G>A
NM_145695.2:c.512G>A
NP_001337634.1:p.Ser171Asn
NP_001337635.1:p.Ser171Asn
NP_001337636.1:p.Ser171Asn
NP_001337637.1:p.Ser171Asn
NP_001337638.1:p.Ser171Asn
NP_001337640.1:p.Ser164Asn
NP_001337641.1:p.Ser164Asn
NP_001337643.1:p.Ser164Asn
NP_001337644.1:p.Ser164Asn
NP_001337645.1:p.Ser164Asn
NP_001337646.1:p.Ser171Asn
NP_001337647.1:p.Ser171Asn
NP_001337648.1:p.Ser171Asn
NP_001337649.1:p.Ser164Asn
NP_001337650.1:p.Ser164Asn
NP_001337651.1:p.Ser129Asn
NP_001337652.1:p.Ser129Asn
NP_001337653.1:p.Ser122Asn
NP_663733.1:p.Ser171Asn
NC_000007.13:g.14741310C>T

Protein change:

S122N

Molecular consequence:

NM_001350705.1:c.512G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350706.2:c.512G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350707.2:c.512G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350708.1:c.512G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350709.2:c.512G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350711.2:c.491G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350712.1:c.491G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350714.2:c.491G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350715.1:c.491G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350716.2:c.491G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350717.2:c.512G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350718.1:c.512G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350719.2:c.512G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350720.1:c.491G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350721.2:c.491G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350722.2:c.386G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350723.2:c.386G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001350724.2:c.365G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_145695.2:c.512G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

S-adenosyl-L-homocysteine hydrolase [Rattus norvegicus]
S-adenosyl-L-homocysteine hydrolase [Rattus norvegicus]
gi|1185363|gb|AAA92043.1|

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003705008	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Apr 8, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003705008

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Apr 8, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV003705008.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The c.512G>A (p.S171N) alteration is located in exon 6 (coding exon 6) of the DGKB gene. This alteration results from a G to A substitution at nucleotide position 512, causing the serine (S) at amino acid position 171 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 3, 2024

ClinVar

Relating variation to medicine